RhumbLine Advisers
DTIL icon

RhumbLine Advisers’s Precision BioSciences DTIL Stock Holding History

RhumbLine Advisers’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.51K Hold
275
– – ﹤0.01% 3957
2025
Q4 		$1.14K Hold
275
– – ﹤0.01% 4025
2025
Q3 		$1.52K Hold
275
– – ﹤0.01% 4006
2025
Q2 		$1.16K Hold
275
– – ﹤0.01% 4029
2025
Q1 		$1.31K Hold
275
– – ﹤0.01% 4011
2024
Q4 		$1.05K Hold
275
– – ﹤0.01% 4075
2024
Q3 		$2.46K Buy
+275
New +$2.65K ﹤0.01% 4049
2022
Q2 		– Sell
-1,655
Closed -$153K – 3136
2022
Q1 		$153K Buy
1,655
+73
+5% +$9.92K ﹤0.01% 2813
2021
Q4 		$351K Sell
1,582
-24
-1% -$6.7K ﹤0.01% 2656
2021
Q3 		$556K Buy
1,606
+78
+5% +$26.4K ﹤0.01% 2501
2021
Q2 		$574K Sell
1,528
-118
-7% -$35.4K ﹤0.01% 2504
2021
Q1 		$511K Sell
1,646
-76
-4% -$26.6K ﹤0.01% 2481
2020
Q4 		$431K Buy
1,722
+160
+10% +$39.2K ﹤0.01% 2497
2020
Q3 		$289K Sell
1,562
-176
-10% -$35K ﹤0.01% 2535
2020
Q2 		$434K Buy
1,738
+502
+41% +$110K ﹤0.01% 2413
2020
Q1 		$224K Buy
1,236
+93
+8% +$24.3K ﹤0.01% 2536
2019
Q4 		$476K Buy
+1,143
New +$359K ﹤0.01% 2381

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RhumbLine Advisers's DTIL Position: Q1 2026 in Review

RhumbLine Advisers held its Precision BioSciences (DTIL) position steady in Q1 2026 at 275 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #3957.

RhumbLine Advisers first reported a position in DTIL in Q4 2019 and has held it in 17 quarters since. The position peaked at $574K in Q2 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • RhumbLine Advisers held 275 shares of Precision BioSciences worth $1.51K as of Q1 2026.
  • RhumbLine Advisers left its Precision BioSciences share count unchanged in Q1 2026.
  • Precision BioSciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #3957 holding.
  • RhumbLine Advisers first reported a position in Precision BioSciences in Q4 2019 and has held it in 17 quarters since.
  • RhumbLine Advisers's Precision BioSciences position peaked at $574K in Q2 2021.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.